VivoSeq
Immunology

Immune System

0

Pipeline Programs↗

4

Active Trials↗

3

Companies Involved↗

Immune System is an early-stage landscape with 0 programs across 3 companies. The most active players are Eli Lilly, Roche, Octapharma.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

0 programs

PreclinicalRoche logo

Roche

0 programs

PreclinicalOctapharma logo

Octapharma

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

32

clinical trials

Completed22 · 69%
Unknown status4 · 13%
Recruiting2 · 6%
Terminated2 · 6%
Active, not recruiting1 · 3%
Not yet recruiting1 · 3%

Clinical Trials

Trial Activity

32 trials

A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants
Recruiting·AAC Immune SA·Phase 1·NCT07463196·78 enrolled
Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development
Recruiting·FFundació Sant Joan de Déu·N/A·NCT07033663·90 enrolled
Opioid, HIV and Immune System
Active, not recruiting·UUniversity of Miami·Phase 4·NCT04304768·400 enrolled
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
Not yet recruiting·Octapharma logoOctapharma·Phase 3·NCT07220915·360 enrolled
Imaging the Neuroimmune System in PTSD
Completed·YYale University·Phase 1·NCT04236986·34 enrolled
A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00000880·30 enrolled
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
Completed·MMayo Clinic·Phase 1·NCT00346619·25 enrolled
Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia
Completed·UUniversity of Alabama at Birmingham·Phase 2·NCT00807625·66 enrolled
Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00001119·288 enrolled
Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00056797·92 enrolled
A Study of Galunisertib on the Immune System in Participants With Cancer
Completed·Eli Lilly logoEli Lilly·Phase 1·NCT02304419·10 enrolled
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Completed·WWake Forest University Health Sciences·N/A·NCT02747407·55 enrolled
The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00004735·81 enrolled
A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00000943·50 enrolled
Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00054860·42 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)